Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.
2.

Central sensitisation and cutaneous allodynia in migraine: implications for treatment.

Landy S, Rice K, Lobo B.

CNS Drugs. 2004;18(6):337-42. Review.

PMID:
15089101
3.

Effects of sensitization of trigeminovascular neurons to triptan therapy during migraine.

Burstein R, Levy D, Jakubowski M.

Rev Neurol (Paris). 2005 Jul;161(6-7):658-60. Review.

PMID:
16141951
4.

Cutaneous allodynia and migraine: another view.

Dahlöf C.

Curr Pain Headache Rep. 2006 Jun;10(3):231-8. Review.

PMID:
18778579
5.

[Mechanism based prevention and treatment of migraine].

Sakai F.

Rinsho Shinkeigaku. 2004 Nov;44(11):809-11. Review. Japanese.

PMID:
15651298
6.

Pathophysiology of migraine--new insights.

Hargreaves RJ, Shepheard SL.

Can J Neurol Sci. 1999 Nov;26 Suppl 3:S12-9. Review.

PMID:
10563228
7.

Serotonin in migraine: theories, animal models and emerging therapies.

Johnson KW, Phebus LA, Cohen ML.

Prog Drug Res. 1998;51:219-44. Review.

PMID:
9949863
8.

Peripheral and central sensitization during migraine.

Malick A, Burstein R.

Funct Neurol. 2000;15 Suppl 3:28-35. Review.

PMID:
11200798
9.

Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.

Pascual J, Mateos V, Roig C, Sanchez-Del-Rio M, Jiménez D.

Headache. 2007 Sep;47(8):1152-68. Review.

PMID:
17883520
10.

Central sensitization theory of migraine: clinical implications.

Dodick D, Silberstein S.

Headache. 2006 Nov;46 Suppl 4:S182-91. Review.

PMID:
17078850
11.

Response properties of dural nociceptors in relation to headache.

Strassman AM, Levy D.

J Neurophysiol. 2006 Mar;95(3):1298-306. Review.

12.

Migraine pathophysiology and its clinical implications.

Silberstein SD.

Cephalalgia. 2004;24 Suppl 2:2-7. Review.

PMID:
15595988
13.
14.

Symptomatic treatment of migraine in children: a systematic review of medication trials.

Damen L, Bruijn JK, Verhagen AP, Berger MY, Passchier J, Koes BW.

Pediatrics. 2005 Aug;116(2):e295-302. Review.

PMID:
16061583
15.

Early treatment in migraine: how strong is the current evidence?

Gendolla A.

Cephalalgia. 2008 Sep;28 Suppl 2:28-35. doi: 10.1111/j.1468-2982.2008.01688.x. Review.

PMID:
18715330
16.

The biology of serotonin receptors: focus on migraine pathophysiology and treatment.

Hamel E.

Can J Neurol Sci. 1999 Nov;26 Suppl 3:S2-6. Review.

PMID:
10563226
17.

[Which triptan is best? Rating of triptans in migraine treatment].

Diener HC.

Pharm Unserer Zeit. 2002;31(5):462-9. Review. German. No abstract available.

PMID:
12369164
18.

The science of migraine.

Burstein R, Jakubowski M, Rauch SD.

J Vestib Res. 2011;21(6):305-14. doi: 10.3233/VES-2012-0433. Review.

19.

[The mechanism of peripheral and central sensitization in migraine. A literature review].

Tajti J, Vécsei L.

Neuropsychopharmacol Hung. 2009 Mar;11(1):15-21. Review. Hungarian.

20.

Neurogenic inflammation in the pathophysiology and treatment of migraine.

Moskowitz MA.

Neurology. 1993 Jun;43(6 Suppl 3):S16-20. Review.

PMID:
8389008

Supplemental Content

Support Center